Clinical Trials · NCT05253066
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
- Phase
- Phase 2/Phase 3
- Recruitment status
- Unknown
- Sponsor
- Shengjing Hospital
- Enrollment
- 130
- Start date
- Feb 2022
- Locations
- See registry
- Primary endpoint
- ORR